With a market expanding over five continents, Key Pharmaceuticals are a developer and manufacturer of generic pharmaceuticals. Presently with twenty-two approved and registered generic drugs in the UK, they distribute these to a network including hospitals, clinics, and pharmacies.
Acquired — 2019
Status — Sold in 2023
Revenue — £10m
